Weleda's Quality Control Analysis Service handles not only analytical and microbiological release testing and methodology development, but also medicinal stability studies in line with ICH Guidelines (International Conference on Harmonisation) in a GMP-compliant (Good Manufacturing Practice) environment. The ICH guidelines stem from the European Union's GMP (EU-GMP). The purpose of standardizing technical standards across the pharmaceuticals industry is to ensure that medicines can be clearly recognized by the respective regulatory authorities in Europe, Japan, and the USA.
Weleda has been using BINDER's KBF 720 constant climate chambers and MKF 240 dynamic climate chambers for years to carry out these studies, not to mention several incubators from the BD and KB series.
Read the whole case study at: